Ertugliflozin (PF-04971729) is a potent, selective and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2), with an IC50 of 0.877 nM for h-SGLT2[1]. Has the potential for the treatment of type 2 diabetes mellitus[2].
Molecular Weight:
436.88
Purity:
99.92
CAS Number:
[1210344-57-2]
Formula:
C22H25ClO7
Target:
SGLT
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
